T. Rowe Price Associates’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $44K | Sell |
|
|||||
|
2024
Q3 | $112K | Buy |
|
|||||
|
2024
Q2 | $84K | Buy |
|
|||||
|
2024
Q1 | $144K | Buy |
|
|||||
|
2023
Q4 | $76K | Hold |
|
|||||
|
2023
Q3 | $117K | Buy |
|
|||||
|
2023
Q2 | $122K | Buy |
|
|||||
|
2023
Q1 | $236K | Buy |
|
|||||
|
2022
Q4 | $197K | Buy |
|
|||||
|
2022
Q3 | $287K | Buy |
|
|||||
|
2022
Q2 | $170K | Buy |
|
|||||
|
2022
Q1 | $194K | Buy |
|
|||||
|
2021
Q4 | $131K | Sell |
|
|||||
|
2021
Q3 | $261K | Sell |
|
|||||
|
2021
Q2 | $4.12M | Sell |
|
|||||
|
2021
Q1 | $5.19M | Sell |
|
|||||
|
2020
Q4 | $22.6M | Buy |
|
|||||
|
2020
Q3 | $21M | Sell |
|
|||||
|
2020
Q2 | $37.2M | Buy |
|
|||||
|
2020
Q1 | $26.8M | Buy |
|
|||||
|
2019
Q4 | $3.25M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $153K | Hold |
|
|||||
|
2017
Q2 | $126K | Buy |
|
|||||
|
2017
Q1 | $178K | Hold |
|
|||||
|
2016
Q4 | $130K | Hold |
|
|||||
|
2016
Q3 | $135K | Hold |
|
|||||
|
2016
Q2 | $93K | Sell |
|
|||||
|
2016
Q1 | $124K | Hold |
|
|||||
|
2015
Q4 | $184K | Buy |
|